Kymera Therapeutics, Inc. (KYMR)

NASDAQ: KYMR · IEX Real-Time Price · USD
20.13
+0.53 (2.70%)
At close: Jun 24, 2022 4:00 PM
20.43
+0.30 (1.49%)
After-hours: Jun 24, 2022 6:20 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018
Selling, General & Admin
36.3518.237.983.77
Research & Development
137.0262.1137.1617.68
Operating Expenses
173.3680.3445.1421.45
Operating Income
-173.36-80.34-45.14-21.45
Interest Expense / Income
0.180.120.050.02
Other Expense / Income
-73.32-34.86-3.940
Pretax Income
-100.22-45.59-41.25-21.47
Net Income
-100.22-45.59-41.25-21.47
Preferred Dividends
09.0500
Net Income Common
-100.22-45.59-41.25-21.47
Shares Outstanding (Basic)
481722
Shares Outstanding (Diluted)
481722
Shares Change
176.60%921.45%-9.44%-
EPS (Basic)
-2.09-3.15-24.28-11.45
EPS (Diluted)
-2.09-3.15-24.28-11.45
Free Cash Flow Per Share
-2.724.5510.23-10.25
EBITDA
-97.65-43.72-40.38-21.25
Depreciation & Amortization
2.41.760.830.21
EBIT
-100.04-45.48-41.2-21.45
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).